Combiflam vs Flexon: Ibuprofen + Paracetamol Brand Comparison & Savings
Detailed clinical comparison of Combiflam vs Flexon: identical active salt compositions, dental pain, arthritis, fever relief, and generic savings.
Both Combiflam (Sanofi) and Flexon (Aristo) contain the identical active pharmaceutical combination: Ibuprofen 400mg + Paracetamol 325mg. Both treat dental pain, muscular body aches, headaches, and inflammatory fevers. They have equivalent clinical efficacy and must both be taken strictly with or after meals to prevent stomach irritation.
1. Identical Active Pharmaceutical Ingredients
Combiflam and Flexon are chemically bioequivalent: each tablet delivers 400mg Ibuprofen (NSAID for inflammation) and 325mg Paracetamol (central analgesic and antipyretic). Neither brand has superior pain relief over the other.
2. Stomach Acid & Gastric Warning
Because both contain 400mg of Ibuprofen, taking either on an empty stomach risks gastric mucosal erosion, heartburn, and ulcers. Always consume after food with plenty of water.
3. Jan Aushadhi Generic Substitute
Branded Combiflam costs ~₹48 for 20 tablets, and Flexon costs ~₹38 for 15 tablets. At Jan Aushadhi Kendras, bioequivalent Ibuprofen 400mg + Paracetamol 325mg tablets cost just ₹9.50 for 10 tablets (up to 80% savings).
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Can I take Combiflam if Flexon is out of stock at the chemist?
Yes, they are 100% therapeutically equivalent and can be interchanged safely under pharmacist supervision.
Q2: Can children take half a Combiflam or Flexon tablet?
No, adult tablets should not be broken for young children. Pediatricians prescribe pediatric suspensions (like Combiflam Syrup) with exact weight-based dosing.
Q3: How does the CDSCO define bioequivalence when comparing two pharmaceutical formulations?
Bioequivalence is confirmed when two pharmaceutical products contain identical active therapeutic moieties and show no statistically significant difference in Cmax and AUC under single-dose fasting and fed pharmacokinetic studies within the 80% to 125% confidence interval.
Q4: When comparing two drugs in the same clinical class, what determines superior therapeutic choice?
Therapeutic selection depends on receptor selectivity, onset speed, elimination half-life, clearance pathway (hepatic CYP450 vs renal excretion), drug interaction liability, and clinical trial evidence regarding organ-specific outcomes.
Q5: Can patients interchange two bioequivalent branded formulations without loss of efficacy?
Yes. Formulations produced under Schedule M Good Manufacturing Practices containing identical active pharmaceutical salts and dissolution profiles can be interchanged safely under pharmacist guidance.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.